Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery
- 537 Downloads
Nose-to-brain drug administration along the olfactory and trigeminal nerve pathways offers an alternative route for the treatment of central nervous system (CNS) disorders. The characterization of particle deposition remains difficult to achieve in experiments. Alternative numerical approach is applied to identify suitable aerosol particle size with maximized inhaled doses.
This study numerically compared the drug delivery efficiency in a realistic human nasal cavity between two aerosol drug administration systems targeting the olfactory region: the aerosol mask system and the breath-powered bi-directional system. Steady inhalation and exhalation flow rates were applied to both delivery systems. The discrete phase particle tracking method was employed to capture the aerosol drug transport and deposition behaviours in the nasal cavity. Both overall and regional deposition characteristics were analysed in detail.
The results demonstrated the breath-powered drug delivery approach can produce superior olfactory deposition with peaking olfactory deposition fractions for diffusive 1 nm particles and inertial 10 μm. While for particles in the range of 10 nm to 2 μm, no significant olfactory deposition can be found, indicating the therapeutic agents should avoid this size range when targeting the olfactory deposition.
The breath-powered bi-directional aerosol delivery approach shows better drug delivery performance globally and locally, and improved drug administration doses can be achieved in targeted olfactory region.
KEY WORDSdrug administration nose-to-brain numerical modelling olfactory particle deposition
Central nervous system
Discrete phase model
Acknowledgments and Disclosures
This study was funded by the National Natural Science Foundation of China (Grant No.: 91643102) and Australian Research Council (Project ID: DP160101953).
- 4.Rissler J, Swietlicki E, Bengtsson A, Boman C, Pagels J, Sandström T, et al. Experimental determination of deposition of diesel exhaust particles in the human respiratory tract. J Aerosol Sci. 2012;48:18–33.Google Scholar
- 5.Bell IR, Koithan M. A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system. BMC Complement Altern Med. 2012;12:191–1.Google Scholar
- 6.Wichers LB, Rowan IIIWH, Nolan JP, Ledbetter AD, McGee JK, Costa DL, et al. Particle Deposition in Spontaneously Hypertensive Rats Exposed via Whole-Body Inhalation: Measured and Estimated Dose. Toxicol Sci. 2006;93(2):400–10.Google Scholar
- 8.Frey WH, Liu J, Chen X, Thorne RG, Fawcett JR, Ala TA, et al. Delivery of 125I-NGF to the Brain via the Olfactory Route. Drug Deliv. 1997;4(2):87–92.Google Scholar
- 11.Chapman CD, Frey WH 2nd, Craft S, Danielyan L, Hallschmid M, Schioth HB, et al. Intranasal treatment of central nervous system dysfunction in humans. Pharm Res. 2013;30(10):2475–84.Google Scholar
- 14.Ross TM, Martinez PM, Renner JC, Thorne RG, Hanson LR, Frey WH 2nd. Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis. J Neuroimmunol. 2004;151(1–2):66–77.CrossRefPubMedGoogle Scholar
- 16.Hanson LR, Frey WH. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 2008;9(Suppl 3):S5–5.Google Scholar
- 20.Kimbell JS, Segal RA, Asgharian B, Wong BA, Schroeter JD, Southall JP, et al. Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages. Journal of Aerosol Medicine: the Official Journal of the International Society for Aerosols in Medicine. 2007;20(1):59–74.Google Scholar
- 24.Dubosky MN, Brahmbhatt H, Vines DL. The Influence of flow rates through nebulizers on aerosol particle size and dose deposition in aerosol masks. Am J Resp Crit Care. 2014;189:A5695.Google Scholar
- 31.Tu J, Inthavong K, Ahmadi G. Computational fluid and particle dynamics in the human respiratory system. In: Biological and Medical Physics, Biomedical Engineering, 1st edn. Netherlands: Springer; 2013. p. 374. https://doi.org/10.1007/978-94-007-4488-2.
- 32.Dong J, Inthavong K, Tu J. Multiphase Flows in Biomedical Applications. In: Yeoh GH, editor. Handbook of Multiphase Flow Science and Technology. Singapore: Springer Singapore; 2017. p. 1–24.Google Scholar
- 35.Tepper SJ, Cady RK, Silberstein S, Messina J, Mahmoud RA, Djupesland PG, et al. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks. Headache. 2015;55(5):621–35.Google Scholar
- 50.Tian L, Shang Y, Chen R, Bai R, Chen C, Inthavong K, et al. A combined experimental and numerical study on upper airway dosimetry of inhaled nanoparticles from an electrical discharge machine shop. Part Fibre Toxicol. 2017;14:24.Google Scholar